Solara Active Pharma Sciences Limited (SOLARA) — Financial Flexibility Index
Solara Active Pharma Sciences Limited (SOLARA) has a Financial Flexibility Index of 0.10x as of September 2025. Free cash flow of Rs1.03 Billion (operating CF Rs740.70 Million minus capex Rs286.00 Million) represents 0% of total liabilities (Rs10.36 Billion). Check SOLARA capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Solara Active Pharma Sciences Limited Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Solara Active Pharma Sciences Limited across 9 annual periods. For the full cash flow conversion analysis, see Solara Active Pharma Sciences Limited cash flow conversion.
Annual Financial Flexibility Index for Solara Active Pharma Sciences Limited (2017–2025)
Year-by-year free cash flow to debt coverage for Solara Active Pharma Sciences Limited. Explore Solara Active Pharma Sciences Limited debt service capacity to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (INR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.22x | Rs2.53 Billion | Rs2.13 Billion | Rs11.35 Billion | ▲ +110.1% |
| 2024 | 0.11x | Rs1.50 Billion | Rs1.09 Billion | Rs14.14 Billion | ▼ -44.7% |
| 2023 | 0.19x | Rs2.68 Billion | Rs1.56 Billion | Rs13.97 Billion | ▲ +913.0% |
| 2022 | -0.02x | Rs-334.10 Million | Rs-2.42 Billion | Rs14.18 Billion | ▼ -107.3% |
| 2021 | 0.32x | Rs3.30 Billion | Rs1.55 Billion | Rs10.21 Billion | ▼ -33.0% |
| 2020 | 0.48x | Rs5.13 Billion | Rs2.44 Billion | Rs10.63 Billion | ▲ +127.1% |
| 2019 | 0.21x | Rs2.12 Billion | Rs1.60 Billion | Rs10.00 Billion | ▲ +166.5% |
| 2018 | 0.08x | Rs839.59 Million | Rs492.23 Million | Rs10.53 Billion | ▼ -100.0% |
| 2017 | 25442.12x | Rs839.59 Million | Rs492.23 Million | Rs33.00K | — |